qRT-PCR data showed that AK treatment increased the expression of not only Pax7 (muscle stem cells, not significant) but also Igf-1 (P < 0.05), which is involved in the hypertrophy of aged muscle (Fig. 6g), thereby supporting the potential of AK as a new candidate therapeutic agent for sarcopenia. The gene discussed is PAX7; the disease is sarcopenia.